Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
127,982,276
-
Share change
-
+3,467,584
-
Total reported value
-
$33,111,816,739
-
Put/Call ratio
-
73%
-
Price per share
-
$258.77
-
Number of holders
-
993
-
Value change
-
+$901,376,761
-
Number of buys
-
358
-
Number of sells
-
453
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2023
As of 31 Dec 2023,
BIOGEN INC. - COM (BIIB) was held by
993 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,982,276 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., and Clearbridge Investments, LLC.
This page lists
994
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.